Search

Author/Creator Jacobs-Cachá, Conxita

2. P134 A preclinical double-blinded, randomized, controlled, multicenter trial (pRCT) on Jak1/Jak2 inhibition in lupus nephritis. (23rd March 2020)

Authors:
Lei, Yutian; Sehnert, Bettina; Voll, Reinhard E; Jacobs-Cachá, Conxita; Soler, Maria Jose; Sanchez-Niño, Maria D; Ortiz, Alberto; Bülow, Roman D; Boor, Peter; Anders, Hans-Joachim
Journal:
Lupus science & medicine
Issue:
Volume 7(2020)Supplement 1
Page Start:
A94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease. (31st January 2020)

Authors:
Górriz, Jose Luis; Navarro-González, Juan F; Ortiz, Alberto; Vergara, Ander; Nuñez, Julio; Jacobs-Cachá, Conxita; Martínez-Castelao, Alberto; Soler, Maria Jose
Journal:
Nephrology dialysis transplantation
Issue:
Volume 35(2020)Supplement 1
Page Start:
i13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The membrane-associated protein 17 (MAP17) is up-regulated in response to empagliflozin on top of RAS blockade in experimental diabetic nephropathy. Issue 1 (5th January 2023)

Authors:
Vergara, Ander; Llorens-Cebrià, Carmen; Martos, Nerea; Martínez-Díaz, Irene; Stein, Frank; Domínguez-Báez, Pamela; Molina-Van den Bosch, Mireia; Rettel, Mandy; Benito, Begoña; Bermejo, Sheila; Pieper, Michael Paul; Jacobs-Cachá, Conxita; Soler, Maria José
Journal:
Clinical science
Issue:
Volume 137:Issue 1(2023)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗